PPT-COPD/ASTHMA Ian Brown, PA-C

Goals Recognize common and uncommon presentations of COPD and asthma Make an appropriate assessment of the severity of illness Prescribe appropriate therapy Disposition the patient appropriately. Asthma and COPD. Dr Rickbir Singh Randhawa. FY1. Definition:. Asthma. Chronic inflammatory airway disease characterised by . reversible airway obstruction. , airway hyper-responsiveness and bronchial inflammation. . and BREATHING . Dr Christopher . Worsnop. Department of Respiratory and Sleep . Medicine. Austin Hospital, Melbourne, Australia. After a short visit to America, . David returns to Italy..  .   . OVERVIEW. D. aryl Freeman. on behalf of the Study Collaborators . Collaborators. Research in Real Life, Cambridge . David Price. Julie von . Ziegenweidt. Laurence . Mascarenhas. Annie Burden. Alison Chisholm. Lauren Clark . Outline . Introduction. Definition. Epidemiology. Etiology. Cost & Burden. Intervention. Research. Introduction. Chronic Lower Respiratory Diseases. Chronic lower respiratory diseases. Alison . Portes. FY1. Objectives. Main features of asthma and COPD. Focus on clinicals – history, examination, investigations, management. 10 minutes on each . Quiz and summary of key points. A few added extras…. An Open Discussion. C. Michael Bowman, PhD, MD. Moderator. Today’s Speakers and You, the Audience. Active Contributors. Objectives for Discussion. Members of the audience will: . Reflect on the various discussion points from today’s talks;. Outline . Introduction. Definition. Epidemiology. Etiology. Cost & Burden. Intervention. Research. Introduction. Chronic Lower Respiratory Diseases. Chronic lower respiratory diseases. : . Asthma, bronchitis, COPD, emphysema, cystic fibrosis, bronchiectasis, pneumoconiosis, sleep apnea. Finlay . Royle. Senior Clinical Commissioning Pharmacist. Lambeth CCG. 1. Medicines Optimisation . Key theme: . Quality. , . Safety . and . Medicines . W. aste. 2. Medicines are the most common therapeutic intervention in healthcare, but their use is often . Dr Rickbir Singh Randhawa. FY1. Definition:. Asthma. Chronic inflammatory airway disease characterised by . reversible airway obstruction. , airway hyper-responsiveness and bronchial inflammation. . Three factors contribute to reversible airway narrowing:. in the Treatment of . Asthma and COPD. Margaret Miklich, . PharmD. , BCACP. Clinical Assistant Professor. 1. m. argaret.miklich@temple.edu. I have no conflicts of interest to disclose.. 2. Pharmacist Objectives. 80 predicted and sometimes but not always Stage II Moderate COPD Worsening airflow limitation FEVbreath typically developing during exertion This is the stage at which patients typically seek medical What is COPD?. How to treat COPD?. What is the prognosis?. 19.3% of US Adults Smoke – 2010. CDC, NHIS 2010. 2010 Current Smokers. %. of Smokers. Demographic. % of Smokers. Demographic. 19.3%. US Adults. Hetal . Dhruve. . Chandra Sarkar. Aims. Overview of spirometry and . interpretion. . Treatment of COPD . COPD Care plans. Questions . Why spirometry?. Discrepancy . in prevalence of COPD from . rightcare. Download PDF Asthma Free Forever™ eBook by Jerry Ericson - A Program That Help People with Asthma to Reduce Their Symptoms Quickly and Get Rid of This Disease.